|Articles|October 14, 2020
Improving Selectivity for Intact Mass Spectrometry of Biotherapeutic mAbs
Author(s)Phenomenex, Inc.
For LC–MS analysis of NIST mAb, multiple C4 LC columns are compared to determine which provides necessary separation of impurity and avoids spectral overlap in the MS detector.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Native Capillary Electrophoresis–Mass Spectrometry Enables Quantitative Profiling of Endogenous Protein Complexes
2
Event Preview: 2nd Green Analytical Chemistry Workshop
3
LC–MS Profiling Reveals Diet- and Hypertension-Specific Alterations in Amino Acid Metabolism
4
Best of the Week: Voices From the Analytical Front Line
5